Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
INIM Pharma AB
AB
Dissolved
Org 5591568471
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 8 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
INIM Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
LE
Linda Elisabeth Sallander
Chief Auditor
Chief Auditor
2022
Former (2)
CJ
Carl Johan Dalsgaard
Chief Executive Officer
Chief Executive Officer
2022 – 2024
AG
Andreas Gunnar Mast
Chief Auditor
Chief Auditor
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
HL
Hans Lennart Jeppsson
Deputy Board Member
Deputy Board Member
2022
AS
Ahmed Shaker Mousa
Board of Directors
Board of Directors
2024
Former (1)
CJ
Carl Johan Dalsgaard
Board of Directors
Board of Directors
2022 – 2024
Shareholders
As of last annual report
Vicore Pharma Holding AB — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Vicore Pharma Holding AB
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on INIM Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
